MedTrace Logo

A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

NCT00002384 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2005-06-24

No results posted yet for this study

Summary

Incomplete Closed Protocol

Conditions

  • Cytomegalovirus Retinitis
  • HIV Infections

Interventions

DRUG

Cidofovir

Sponsors & Collaborators

  • Anderson Clinical Research

    collaborator INDUSTRY

  • Gilead Sciences

    lead INDUSTRY

Study Design

Purpose
TREATMENT

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002384 on ClinicalTrials.gov